Search clinical trials for: Vorinostat (VOR)
Total 17946 results
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID)CompletedHIV-1 InfectionUnited States
-
University of North Carolina, Chapel HillNational Institute of Allergy and Infectious Diseases (NIAID); Merck Sharp... and other collaboratorsCompletedThe Effect of Vorinostat on HIV RNA Expression in the Resting CD4+ T Cells of HIV+ Pts on Stable ARTHIV-1 InfectionUnited States
-
Peter MacCallum Cancer Centre, AustraliaGlaxoSmithKline; Merck Sharp & Dohme LLCTerminatedFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone LymphomaAustralia
-
Katy PetersMerck Sharp & Dohme LLC; Genentech, Inc.CompletedGlioblastoma | Brain TumorUnited States
-
Indiana University School of MedicineBayerCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Promyelocytic, AcuteUnited States
-
Armando Santoro, MDTerminatedSmall Cell Lung CancerItaly
-
The Methodist Hospital Research InstituteWithdrawnNon-Hodgkin Lymphoma
-
Merck Sharp & Dohme LLCCompleted
-
Groupe Francophone des MyelodysplasiesMerck Sharp & Dohme LLCTerminated
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Virginia Commonwealth UniversityWithdrawn
-
National Center for Tumor Diseases, HeidelbergMerck Sharp & Dohme LLC; University Hospital HeidelbergCompleted
-
Fox Chase Cancer CenterNational Comprehensive Cancer NetworkCompletedLocally Advanced Non-small Cell Lung CancerUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)CompletedLymphoma | Leukemia | Small Intestine Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
University of CalgaryUnknown
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCNo longer availableLymphoma, T-Cell, Cutaneous
-
Institut Claudius RegaudMerck Sharp & Dohme LLCTerminatedMalignant Solid TumourFrance
-
Ohio State University Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedLymphoma | Small Intestine CancerUnited States
-
Medical University of GrazTerminatedLeiomyosarcoma | Endometrial Stromal Tumors | Carcinosarcomas UterineAustria
-
Merck Sharp & Dohme LLCTerminated
-
Groupe Francophone des MyelodysplasiesMerck Sharp & Dohme LLCCompletedMyelodysplastic SyndromesFrance
-
University of VirginiaCompletedNon Small Cell Lung CancerUnited States
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
Merck Sharp & Dohme LLCTerminatedMyelodysplastic Syndromes | Blood Disease | Bone Marrow Disease
-
German Center for Neurodegenerative Diseases (DZNE)University Hospital, Bonn; University of GöttingenTerminated
-
Merck Sharp & Dohme LLCTerminatedBreast Cancer | Colorectal Cancer | Non-small-cell Lung Carcinoma
-
National Cancer Institute (NCI)CompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute... and other conditionsUnited States
-
Merck Sharp & Dohme LLCTerminated
-
European Organisation for Research and Treatment...Withdrawn
-
Merck Sharp & Dohme LLCCompletedAdvanced Cancer Relapsed | Advanced Cancer Refractory
-
National Cancer Institute (NCI)CompletedBreast Cancer | Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Recurrent Breast CancerUnited States
-
University of Wisconsin, MadisonMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.CompletedCarcinoma, Non Small Cell Lung
-
National Cancer Institute (NCI)CompletedRecurrent Melanoma | Stage IV Melanoma | Uveal Melanoma | Ciliary Body and Choroid Melanoma, Medium/Large Size | Iris Melanoma | Recurrent Intraocular Melanoma | Extraocular Extension MelanomaCanada, United States
-
Dana-Farber Cancer InstituteMerck Sharp & Dohme LLC; Boston Children's Hospital; Brigham and Women's HospitalTerminatedSickle Cell Disease | Sickle Cell AnemiaUnited States
-
Weill Medical College of Cornell UniversityMerck Sharp & Dohme LLC; CelgeneCompleted
-
Masonic Cancer Center, University of MinnesotaMerck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.TerminatedLeukemia | Myelodysplastic SyndromeUnited States
-
National Cancer Institute (NCI)CompletedSarcoma | Lymphoma | Neuroblastoma | WilmsTumorUnited States
-
National Cancer Institute (NCI)Gynecologic Oncology GroupCompletedPrimary Peritoneal Cavity Cancer | Recurrent Ovarian Epithelial CancerUnited States
-
Kanazawa UniversityUnknownNon-Small-Cell Lung CarcinomaJapan
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)CompletedInsular Thyroid Cancer | Recurrent Thyroid Cancer | Stage II Follicular Thyroid Cancer | Stage II Papillary Thyroid Cancer | Stage IV Follicular Thyroid Cancer | Stage IV Papillary Thyroid Cancer | Thyroid Gland Medullary CarcinomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage IV Prostate CancerUnited States
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedStage IIIB Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung CancerUnited States
-
Hamid SayarBayer; Merck Sharp & Dohme LLC; Millennium Pharmaceuticals, Inc.Completed